Myelofibrosis arising in treated histiocytosis X.
Myelofibrosis, or fibrous replacement of hematopoietic bone marrow, is rarely encountered in pediatric patients. An unusual, reversible case arising in the setting of treated histiocytosis X is reported, a previously undescribed association. The clinical, pathologic, radiographic, and scintigraphic characteristics of myelofibrosis are reviewed.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007223:Infant; D008297:Male; D010026:Osteosclerosis / Q000139:chemically induced / Q000175:diagnosis; D055728:Primary Myelofibrosis / Q000139:chemically induced* / Q000175:diagnosis / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging
D000970:Antineoplastic Agents